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Macrophages are important immune cells operating at the forefront of innate immunity by
taking up foreign particles and microbes through phagocytosis. The RAW 264.7 cell line is
commonly used for experiments in the macrophage and phagocytosis field. However, little is
known how its functions compare to primary macrophages. Here, we have performed an in-
depth proteomics characterization of phagosomes from RAW 264.7 and bone marrow derived
macrophages by quantifyingmore than 2500 phagosomal proteins. Our data indicate that there
are significant differences for a large number of proteins including important receptors such as
mannose receptor 1 and Siglec-1. Moreover, bone marrow derived macrophages phagosomes
mature considerably faster by fusion with endosomes and the lysosome which we validated
using fluorogenic phagocytic assays. We provide a valuable resource for researcher in the
field and recommend careful use of the RAW 264.7 cell line when studying phagosome func-
tions. All MS data have been deposited in the ProteomeXchange with identifier PXD001293
(http://proteomecentral.proteomexchange.org/dataset/PXD001293).
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Macrophages are immune cells that exist in many differ-
ent tissues and perform a wide range of biological functions
[1, 2]. They are extremely plastic in their protein expression
pattern and can become activated by a range of cytokines and
pathogen-associated molecules such as lipopolysaccharide.
One of the main functions of macrophages is phagocytosis,
which is the active uptake of large particles (> 0.5 m) by
cells [3]. Phagocytosis is an important cellular mechanism
for almost all eukaryotes, highly conserved from amoeba
to human [4], in mammals, it is a key part of the in-
nate immune response against invading microorganisms.
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Moreover, macrophages phagocytose apoptotic cells and cell
debris to recycle cellular building blocks during homeosta-
sis and development [5, 6]. Phagocytosis is induced through
the binding of particles to cell surface receptors such as the
mannose receptor, Fc-receptors, or scavenger receptors. After
internalization, newly formed phagosomes engage in a mat-
uration process that involves fusion with endosomes, lyso-
somes, and other organelles [7,8] leading to the formation of
phagolysosomes in which the foreign matter is degraded.
Peptide antigens from the particle are also presented via
MHC class I and II molecules, bridging innate and adaptive
immunity.
The macrophage-like cell line RAW 264.7 [9] was derived
from Balb/c mice injected with Abelson murine leukemia
virus and has been extensively used in the phagocytosis and
macrophage field in the past with almost 4000 articles listed
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Figure 1. BMDMs display an increased rate
of phagocytosis, phagosomal acidification,
and proteolysis compared to RAW 264.7
macrophages. (A) BMDMs show a strongly in-
creased efficiency of phagocytosis of AF-488-
coated 3 m beads compared to RAW 264.7
cells. Cells treatedwith the actin polymerization
inhibitor cytochalasin D were used as non-
phagocytic negative controls. Error bars repre-
sent standard deviation, pair-wise t-test com-
parison with ***p < 0.0001 and **p < 0.001.
(B–D) Real-time kinetics of fluorescent phago-
some assays. BMDM phagosomes acidify sig-
nificantly faster (B), display a much faster and
stronger phagosomal proteolysis (C) but a sim-
ilar oxidative burst (D) compared to RAW 264.7
cells. Shaded areas around lines are the stan-
dard error of mean (SEM) of six replicates.
in Pubmed in 2014. In recent years, the cell line has also
been used extensively in proteomics experiments including
a large-scale proteome [10], phagosome proteomics [4, 8, 11],
responses to cytokines [12, 13], and identification of DNA
receptors [14].
In this paper, we have compared the phagosomal func-
tions and proteomes of RAW 264.7 and bonemarrow derived
macrophages (BMDMs) [15, 16] in order to determine if the
cell line was a good substitute for primarymacrophages when
studying phagosome and macrophage biology.
First, we performed a set of experiments to characterize
differences in phagocytic uptake of beads and phagosome
maturation in RAW 264.7 and BMDMs. Phagocytic uptake
assays using Alexafluor488-labeled 3 m silica beads showed
a significantly reduced phagocytosis rate in RAW 264.7 com-
pared to BMDM, particularly at early time points (Fig. 1A).
Moreover, we performed fluorogenic assays to measure pH,
proteolysis, and oxidative capacity of phagosomes in real time
[17–19] and identified a significant faster phagosome acidi-
fication in BMDMs (Fig. 1B), which is possibly due to the
faster phagocytosis compared to RAW 264.7 cells. However,
BMDMs also display a much stronger proteolytic activity,
suggesting a quicker fusion with lysosomes, a reduced inacti-
vation of lysosomal proteases, and/or a higher concentration
of proteases in the lysosome (Fig. 1C). Interestingly, RAW
264.7 cells produce a similar or even slightly higher oxida-
tive burst in phagosomes compared to BMDMs (Fig. 1D),
suggesting that this function is well conserved in the cell
line.
In order to get insights into the molecular differences
of the RAW 264.7 and BMDM phagosome proteomes, we
performed a label-free proteome analysis of phagosomes
from both cell types. Phagocytosis was induced for 30 min
using carboxylated 1 m polystyrene beads (Estapor/EMD
Millipore) and phagosomes were isolated using sucrose
ultracentrifugation in which the phagosomes float above
cell debris and other organelles [11, 20]. Protein extracts
from three biological replicates were resuspended in 1%
sodium 3-[(2-methyl-2-undecyl-1,3-dioxolan-4-yl)methoxy]-1-
propanesulfonate (commercially available as RapiGest, Wa-
ters) in 50 mM Tris-HCl pH 8.0 with 5 mM tris(2-
carboxyethyl)phosphine (TCEP, Pierce), heated at 60C for
5 min, then alkylated using 10 mM iodoacetamide, diluted to
0.1% RapiGest and finally trysinized overnight at 30C. After
SPE clean-up, 2 g of each sample was injected onto an Orbi-
trap Fusionmass spectrometer (Thermo-Fisher Scientific) via
a 50 cm long 75 m column using a 6 h gradient delivered by
a Dionex U-3000 LC system (Thermo-Fisher Scientific). Data
were acquired with a resolution of 120 000 in MS1 and a scan
range of 400–1600. Peptide ions were fragmented by HCD
(35% collision energy) with a resolution of 15 000, an AGC
target of 50 000, and amaximum injection time of 60ms. The
whole duty cycle was set to 2.5 s during which the instrument
performed “top speed” analysis. Data were analyzed by label-
free quantitation usingMaxQuant v1.5.0.12 [21] and searched
against a murine Uniprot-Trembl database (51 372 entries;
downloaded February 19 2014) and a list of common con-
taminants. This resulted in an identification of 3535 proteins
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Figure 2. GO-term enrichment
and phagosome network anal-
yses. (A) Selected GO terms
of proteins enriched in the
phagosome proteomes isolated
from either BMDM or RAW
264.7 cells. (B) The phagosome
network analysis shows cellu-
lar processes that were signifi-
cantly enriched in the phagoso-
mal proteome of BMDM (green)
or decreased (red) compared
to RAW 264.7 cells. The con-
nection (gray edges) between
nodes represents experimen-
tally proven physical interaction
between proteins.
(<1% FDR) and quantitation of 2510 proteins (present in two
of the three replicates), providing the detailed analysis of the
phagosome proteome so far (Supporting Information Table
1). A total of 290 and 226 proteins were significantly enriched
(twofold, p < 0.05) on BMDM and RAW 264.7 phagosomes,
respectively. Fifty eight BMDM and 17 RAW 264.7 proteins
were considered unique to their cell line (a minimum of five
quantified peptides in one and no quantitative values identi-
fied in the other cell type).
GO enrichment analysis of the proteins enriched on RAW
264.7 phagosomes compared to BMDM (Fig. 2A) includes
ribosomes and translation proteins, which are probably over-
represented as RAW 264.7 is an actively proliferating cell
line compared to BMDMs. Moreover, the vATPase complex
is strongly enriched, although our functional data (Fig. 1B)
showed a clear delay of the acidification in RAW 264.7. In-
terestingly, two vATPase subunits, ATP6v0a1 and ATP6ap2
(Renin receptor), are more abundant on BMDMphagosomes
(Fig. 2B), suggesting they have an important role in the reg-
ulation of the acidifying complex. BMDM phagosomes have
protein complexes enriched in the innate immune response,
such as TLR 9 and TLR13 as well as complement recep-
tors. Furthermore, they have strongly enriched integrin com-
plexes (including integrins alpha-5, alpha 6, beta-1, beta-2,
and beta-5) and express higher levels of lectins such as man-
nose receptor 1 (MRC1), galectins 1, 3, 8, and 9 as well as
C© 2014 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
3172 M. Guo et al. Proteomics 2015, 15, 3169–3174
Figure 3. Validation of the pro-
teomics results. (A) Western
blotting analysis of six proteins
selected from the proteomics
data. P, phagosome; TM, total
membrane extract; TCL, total
cell lysate. Log2 ratios of pro-
teomics results are given for
convenience. (B) Fluorescence
microscopy of Rab7a, Siglec-1,
and Syk proteins showed much
stronger expression of Siglec-
1 in BMDMs than RAW 264.7
cells. Rab7a was localized to the
phagosome in both cell types
but Siglec-1 and Syk were only
associated with the phagosome
in BMDMs. (C) The efficiency
of phagocytosis of mannan-
coated beads is strongly in-
creased in BMDMs compared
to RAW 264.7 cells, due to the
much higher expression ofman-
nose receptor 1 (MRC1). Error
bars represent standard devia-
tion, pair-wise t-test comparison
with ***p < 0.0001 and **p <
0.001.
chitinase-like protein 3 (Chil3/Ym1) and Sialoadhesin
(Siglec1). Interestingly, BMDMs express also four timesmore
Clec10a (Mgl1) which has been used with MRC1 and Ym1 as
markers for alternatively activated macrophages [22]. RAW
264.7, on the other hand, express higher levels of Clec4e
(Mincle), Clec4a (Dcir), and Clec7a (Dectin 1), as well as a
fourfold higher amount of interferon- receptor, suggesting
that the basal activation state of RAW 264.7 cells is consider-
ably more proinflammatory compared to BMDMs.
Next, we performed a STRING analysis [23] of the pro-
teins enriched in BMDMs and RAW 264.7 cells (Fig. 2B).
This showed that various protein complexes are significantly
enriched on BMDM phagosomes, including septin 2, 7, 8, 9,
and 11, which have recently been shown to be important for
phagosome formation [24], several complexes of cytoskele-
ton proteins associated with ezrin, moesin and Rock2 and
Evl [25], proteins of the ESCRT complexes [26], the striatin
complex [27] that has not previously been shown to locate to
the phagosome, the above-mentioned integrin complex, and
the entire antigen crosspresentation complex associated with
Tap2. One would therefore expect considerable differences in
the ability to cross-present antigens via MHC class I between
RAW 264.7 cells and BMDMs.
We validated our proteomics results independently using
Western blotting for a number of proteins (Fig. 3A). In RAW
264.7 cells, we confirmed a strong phagosomal enrichment of
annexin-V representing a larger number of annexins, indica-
tive of a higher phospholipid content on RAW 264.7 phago-
somes. Our data further show that Siglec1 is indeed only ex-
pressed in BMDMs.Moreover, we noticed that Syk, an impor-
tant kinase for phagocytosis through various receptors [28], is
located strongly to the phagosome in BMDMs, while it is not
enriched in RAW264.7 cells, with themajority being found in
the total cell lysate. We further validated this by fluorescence
microscopy (Fig. 3B), showing strong enrichment on BMDM
phagosomes for Siglec-1 and specific translocation for Syk.
Finally, as discussed above, we identified a >1000-fold
larger amount of MRC1 on phagosomes from BMDMs com-
pared to RAW 264.7. This led us to investigate if uptake of
beads coated with the polysaccharide mannan (Dill et al.,
submitted), which is taken up through mannose receptor
[29], was affected between the two cell types. Figure 3C
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indeed shows an even stronger difference in phagocytic up-
take of mannosylated beads than uncoated beads (Fig. 1A),
indicating that MRC1 enhances the uptake of these beads in
BMDMs.
In conclusion, we provide the largest dataset of themurine
phagosome proteome published so far, which will be an
important resource for researchers in the phagocytosis and
macrophage field. Furthermore, our data indicate that sev-
eral phagosomal functions such as acidification and prote-
olysis are significantly reduced in the RAW 264.7 cell line
compared to BMDMs from C57/BL6 mice. By showing the
molecular differences and similarities on the phagosome of
these cell types, we allow researchers to choose the bestmodel
for their protein of interest.
The MS proteomics data in this paper have been deposited
in the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE partner repository [30]:
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